Literature DB >> 11572144

Applying molecular biological techniques to detecting biological agents.

A E Krafft1, D A Kulesh.   

Abstract

Recent efforts in the civilian and military health care and public health communities are directed at strengthening surveillance systems and our national laboratory capabilities for early detection of infectious disease outbreaks. These new systems will address proper specimen collection, transport, nucleic acid processing, molecular assay diagnostic reagent and equipment development, and standardization for sensitive and rapid detection of bioagents in blood and other clinical samples. A greater understanding of the genetic diversity and virulence factors for each organism that could be used for bioterrorism would aid design of rapid molecular detection strategies. Combinations of appropriate diagnostic technologies (culture, immunoassay, and molecular assay) can provide rapid diagnostic response capabilities to microbial threats with antimicrobial resistant organisms, new emerging infectious disease agents, and possible agents of bioterrorism.

Entities:  

Mesh:

Year:  2001        PMID: 11572144

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  3 in total

1.  Smallpox and pan-orthopox virus detection by real-time 3'-minor groove binder TaqMan assays on the roche LightCycler and the Cepheid smart Cycler platforms.

Authors:  David A Kulesh; Robert O Baker; Bonnie M Loveless; David Norwood; Susan H Zwiers; Eric Mucker; Chris Hartmann; Rafael Herrera; David Miller; Deanna Christensen; Leonard P Wasieloski; John Huggins; Peter B Jahrling
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  Developments in the Diagnostic Techniques of Infectious Diseases: Rural and Urban Prospective.

Authors:  Shweta Srivastava; Prabhat K Singh; Vatsalya Vatsalya; Robert C Karch
Journal:  Adv Infect Dis       Date:  2018-08-23

Review 3.  The initial hospital response to an epidemic.

Authors:  Nicola Petrosillo; Vincenzo Puro; Antonino Di Caro; Giuseppe Ippolito
Journal:  Arch Med Res       Date:  2005 Nov-Dec       Impact factor: 2.235

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.